日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Arsenic trioxide for reprogramming the bone marrow microenvironment to eliminate acute myeloid leukemia blasts

三氧化二砷用于重编程骨髓微环境以消除急性髓系白血病原始细胞

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70191
Kegyes, David; Teodorescu, Patric; Supeanu, Teodora; Nagai, Yuya; Zhong, Guo; Mathews, Vikram; Isoherranen, Nina; Ghiaur, Gabriel
白血病
细胞生物学
发表日期：2025
文献求助 收藏

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies

急性髓系白血病可测量残留病灶评估的进展：从细胞遗传学和分子生物学到甲基化模式评估和表面增强拉曼散射等新兴技术

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00869-w
Bancos, Anamaria; Ivancuta, Andrei; Moisoiu, Vlad; Tigu, Adrian-Bogdan; Gulei, Diana; Nistor, Madalina; Moldovan, Cristian-Silviu; Kegyes, David; Cenariu, Diana; Zdrenghea, Mihnea; Bojan, Anca; Iancu, Stefania D; Leopold, Nicolae; Ghiaur, Gabriel; Bumbea, Horia; Tanase, Alina; Einsele, Hermann; Ciurea, Stefan O; Tomuleasa, Ciprian
白血病
细胞生物学
表观遗传
发表日期：2025
文献求助 收藏

Humanized mouse models in MDS

MDS中的人源化小鼠模型

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07861-0
Munteanu, Raluca; Gulei, Diana; Moldovan, Cristian Silviu; Azzoni, Emanuele; Belver, Laura; Feder, Richard; Pirv, Simina; Buzoianu, Anca Dana; Einsele, Hermann; Mittelman, Moshe; Ghiaur, Gabriel; Hasserjian, Robert; Tomuleasa, Ciprian
Human
发表日期：2025
文献求助 收藏

Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy

在移植前治疗效果日益显著的时代，采用高剂量移植后环磷酰胺治疗异基因造血干细胞移植或骨髓移植可改善急性淋巴细胞白血病患者的预后。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.287433
Webster, Jonathan A; Reed, Madison; Tsai, Hua-Ling; Imus, Philip H; Smith, Douglas B; Ambinder, Alexander J; Levis, Mark J; DeZern, Amy E; Prince, Gabrielle T; Jain, Tania; Bolaños-Meade, Javier; Gondek, Lukasz P; Ghiaur, Gabriel; Dalton, William Brian; Karantanos, Theodoros; Paul, Suman; Fuchs, Ephraim J; Sterling, Cole; Swinnen, Lode J; Wagner-Johnston, Nina; Ambinder, Richard F; Gocke, Christian B; Ali, Syed Abbas; Huff, Carol Ann; Luznik, Leo; Varadhan, Ravi; Jones, Richard J; Gojo, Ivana
白血病
细胞生物学
发育与干细胞
干细胞
发表日期：2025
文献求助 收藏

Comprehensive characterization of human bone marrow microenvironment shows age-related changes

对人类骨髓微环境的全面表征揭示了其随年龄变化的特征。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.287536
Peters, Mareike; Teodorescu, Patric; Pasca, Sergiu; Zhang, Xuan; Wang, Rulin; Yegnasubramanian, Srinivasan; Grimes, Leighton H; Salomonis, Nathan; Gondek, Lukasz P; Ghiaur, Gabriel
发表日期：2025
文献求助 收藏

A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia

一项关于口服三氧化二砷治疗急性早幼粒细胞白血病患者的药代动力学和安全性研究

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015453
Ravandi, Farhad; Rangaraju, Sravanti; Kantarjian, Hagop; Garcia-Manero, Guillermo; Yilmaz, Musa; Baker, Kristen; Hall, Terence; Grabenstein, Joy; Roy, Pourab; Zamboni, Beth A; Zamboni, William C; Warlick, Erica; Kelly, Michael; Roth, David A; Ghiaur, Gabriel
白血病
细胞生物学
粒细胞
发表日期：2025
文献求助 收藏

Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies

全面探讨使用维奈托克联合靶向和/或免疫疗法治疗急性髓系白血病的无化疗方案

期刊:Cell Death Discovery
影响因子:7
doi:10.1038/s41420-025-02678-4
Kegyes, David; Tat, Andrei; Vizitiu, Alin Stefan; Vazar-Tripon, Daiana; Ilie, Radu; Tigu, Adrian Bogdan; Cenariu, Diana; Bancos, Anamaria; Iluta, Sabina; Jitaru, Ciprian; Nistor, Madalina; Tomai, Radu; Gulei, Diana; Zdrenghea, Mihnea; Einsele, Hermann; Ghiaur, Gabriel; Croce, Carlo M; Tomuleasa, Ciprian
白血病
免疫/内分泌
发表日期：2025
文献求助 收藏

FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML

FLT3：从发现到下一代急性髓系白血病靶向治疗的35年历程

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17213415
Stancioaica, Maria-Camelia; Coriu, Daniel; Ghiaur, Gabriel
白血病
FLT3
发表日期：2025
文献求助 收藏

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities

blinatumomab治疗CD19+急性白血病患者的疗效和安全性研究（患者既往因合并症而被排除在临床试验之外）

期刊:Leukemia Research
影响因子:2.2
doi:10.1016/j.leukres.2025.108098
Claiborne, J Preston; Li, Daniel; Tsai, Hua-Ling; Ghiaur, Gabriel; Smith, B Douglas; Levis, Mark J; DeZern, Amy E; Ambinder, Alex J; Jain, Tania; Prince, Gabrielle T; Gondek, Lukasz P; Karantanos, Theodoros; Dalton, W Brian; Gojo, Ivana; Webster, Jonathan A
白血病
CD19
发表日期：2025
文献求助 收藏

Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML

对于年龄在 60 至 75 岁之间、预后良好且携带 NPM1 突变的急性髓系白血病 (AML) 患者，强化化疗与维奈托克/去甲基化药物的比较

期刊:
影响因子:
doi:10.1016/j.bneo.2025.100133
Zale, Andrew D; Sandeep Kaduluri, Venkata Preetam; Webster, Jonathan A; Levis, Mark J; Gojo, Ivana; DeZern, Amy E; Ghiaur, Gabriel; Gondek, Lukasz P; Dalton, William Brian; Karantanos, Theodoros; Jain, Tania; Prince, Gabrielle T; Jones, Richard J; Smith, B Douglas; Ambinder, Alexander J
白血病
NPM
表观遗传
发表日期：2025
文献求助 收藏